Read this case study to learn how a company engaged with Catalent to develop an oral lipid-based formulation that would lead to a more predictable and reliable drug response.
Summary: In this webinar, experts will explore the current investment and clinical landscape of Targeted Protein Degraders.
Summary: Experts explore the challenges of orphan drug development and manufacturing and will discuss how the industry is leveraging strategic partnerships to help mitigate these challenges to create a viable orphan drug business model.
Summary: Experts review the trends and challenges associated with the rational design of targeted protein degrader drugs. In addition, experts also share perspectives on how to inform the selection and development of orally bioavailable…
Summary: This eBook explores the challenges and strategies involved in developing and manufacturing HPAPIs as well as highlights the benefits of partnering with an experienced CDMO that can effectively address the challenges of manufacturing potent drugs and…
Summary: During this webinar learn with the right combination of technology and expertise, micronization can help to overcome many of the challenges faced by small molecule drugs and address the challenges and solutions to scale, yield and cost of goods.
